APA (7th ed.) Citation

Franken, M., Nilsson, F., Sandmann, F., de Boer, A., & Koopmanschap, M. (2012). RE2 A Detailed Comparison of Dutch and Swedish Drug Reimbursement Decisions: What Evidence is Available, Which Criteria are Used, and is the Decision-Making Process Transparent? Value in Health, 15(7), A287. https://doi.org/10.1016/j.jval.2012.08.534

Chicago Style (17th ed.) Citation

Franken, M.G, F. Nilsson, F. Sandmann, A. de Boer, and M.A Koopmanschap. "RE2 A Detailed Comparison of Dutch and Swedish Drug Reimbursement Decisions: What Evidence Is Available, Which Criteria Are Used, and Is the Decision-Making Process Transparent?" Value in Health 15, no. 7 (2012): A287. https://doi.org/10.1016/j.jval.2012.08.534.

MLA (9th ed.) Citation

Franken, M.G, et al. "RE2 A Detailed Comparison of Dutch and Swedish Drug Reimbursement Decisions: What Evidence Is Available, Which Criteria Are Used, and Is the Decision-Making Process Transparent?" Value in Health, vol. 15, no. 7, 2012, p. A287, https://doi.org/10.1016/j.jval.2012.08.534.